Grifols (GRFS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Is Grifols (GRFS) Stock Undervalued Right Now?

11:17am, Monday, 27'th Feb 2023
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Grifols is a global, Spanish-based biotech company that is a favorite for many European investors, despite the fact that the company does not pay a dividend. It's one of the more well-known Spanish co
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
GEVO, GRFS and ABM have been added to the Zacks Rank #5 (Strong Sell) List on January 13, 2023.

New Strong Sell Stocks for January 13th

07:32am, Friday, 13'th Jan 2023
GEVO, GRFS and ABM have been added to the Zacks Rank #5 (Strong Sell) List on January 13, 2023.

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

10:20am, Wednesday, 14'th Sep 2022 Zacks Investment Research
Sector ETF report for FBT

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

10:20am, Friday, 09'th Sep 2022 Zacks Investment Research
Smart Beta ETF report for FBT
Gainers Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11, 20
Gainers Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) gained 231% to $2.63 on news that the company will be acquired By Henry Crown and Company for $3.25 per share. Petros Pharmaceuticals, however, con
Bausch Health Companies Inc. (NYSE: BHC) shares fell 50.3% to $4.3166 following reports of an order on a patent litigation over Xifaxan. Pathward Financial, Inc. (NASDAQ: CASH) fell 25.2% to $32.26

3 Ways To Take Advantage Of The Fed's Rate Hikes

04:05pm, Tuesday, 26'th Jul 2022 Investing.com
According to model portfolio statistics, five stocks in the Historical Low Price-Sales Model Portfolio that have gained more than 6% in the year to date are Banco de Chile ( BCH , Financial), LTC Prop
These three healthcare stocks should hold their value for years.
These three healthcare stocks should hold their value for years.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE